Slide 1

PharmEvo (Private) Limited, 402, Business Avenue, Block-6, P.E.C.H.S., Shahrah-e-Faisal, Post Box 3156, Karachi-75400 PAKISTAN.Tele. (+92-21) 3431 5195-7, 3455 6330, Fax: (+92-21) 3455 6344Our Dream A Healthier Society PharmEvo

Total Area:803,940 SQ. KMProvinces:5Cities:105

Population:181 MILLION Male:51%Female:49%Population Growth:2.03 % P.A.

Life ExpectancyMale:64 YEARSFemale:66 YEARS

Population DistributionRural:64%Urban:36%

Per Capita Income:$ 1,372 P.A.DEMOGRAPHY

DEMOGRAPHY

DEMOGRAPHY

Major Hospitals:Nos. 965Teaching Hospitals:Nos. 64Dispensaries:Nos. 4,916Basic Health Units:Nos. 5,349Maternity Homes:Nos. 1,138Medical Colleges:Nos. 68Diabetic Care Centers:Nos. 200 approx.No. of Beds:109,005Ratio to Population:1 :1,575Registered Doctors:Nos. 137,956Ratio to Population:1 : 1,206No. of Dentists:9,462Ratio to Population:1 : 16,426No. of Nurses:68,387Ratio to Population:1 : 3,664No. of Nursing Schools:14Crude Birth Rate:24.3 / 1,000Crude Death Rate:6.8 / 1,000

Pakistans Healthcare Data Ref- MOH and Economic Survey of Pakistan.

Drug Price are officially controlled, Prices seized since 2000.Pakistans Pharma Market Data. Ref: 2012 - IMS Health Pakistan ( PKPI)Total No. Of Companies

811Total Pharmaceutical MarketRs. 175 B

US $1.9B

G.R 18%

MNC 23

National Pharma 788

Pakistans Pharma Market Data. Ref: 2012 - IMS Health Pakistan ( PKPI)

Premier Group of CompaniesPremier DistributorsPremier AgenciesPharmEvoZaman TextilesShield Corporation

8

US$ 50 million in 2005 to US$ 210 Million in 2011

Growth History - Group20052012

US$ 210 Million US$ 50 million (15% growth comes from existing account & rest from new accounts)

9

English Biscuits Mfg: Largest Biscuit / confectionary company in Pakistan, Group has 20% shareholding.

National Foods Ltd.: Largest package food company in Pakistan, 5% shareholding. Mr. Ebrahim Qassim is the board member of both the companies.

Mr. Haroon Qassim is the board member of English Biscuits Mfg.

GROUPs INVESTMENT

10

Committed Partnership

English Biscuits PF (in 1987 equity participation)197137 yearsNational Foods (in 1995 equity participation)197335 yearsSanofi Aventis197533 yearsMitchells1979 29 yearsShield Corporation Limited197929 yearsUnilever Pakistan - Rafhan Best Foods (1980 to 2008)28 yearsSearle (1973 to 1998)26 yearsBecton Dickinson198919 yearsToyo Nasic199315 yearsCadbury Pakistan198919 yearsAbbott Nutrition International 200008 years

PREMIER GROUP

11

PREMIER Distributors Consumer Division Since 1971

12

PREMIER AGENCIESPharma Division

13

Started its operation in 1985 Acquired by the group in 2003Leading manufacturers of export quality 100% cotton yarnExport regions include Asia, Africa, and South AmericaAggressive expansion plans in progress, planned for the next 3 years

Zaman Textiles

Started its operations in 1984

Over 30% market share in baby care products (feeders, soothers, nipples, and teethers) within the local market

Did Contract manufacturing for Gillette Pakistan for their Oral B and Contra lines of brushes until P&G took over.

Shield Corporation

Plant Karachi, Pakistan

PharmaceuticalsNutrition(Celia)Diagnostics(Omron)Healthcare Portfolio

PharmEvo Pvt. LtdBiotechnologyOncology

Other Rx

Diagnostics(Omron)

OMRON Corporation based in Japan since 1933, with a presence nearly all regions of the world.

Capital:$ 0.76 billion (March , 2010)Net Sales:$ 6.25 billion (March , 2010)

OMRON Group Employees: 36,299

Blood Pressure MonitorsDigital ThermometersBody Composition MonitorsPedometersNebulizerOthersProduct Lineup

Lactalis Worlds Largest Dairy / Nutritional based in France, with a presence nearly 150 countries.Nutrition(Celia)

Turn Over 11 billion EuroStaff36,500Industrial Sites125Collection9.2 Billion liters in the world

Pharmaceuticals

VISION

Our dream is to build a healthier society by becoming a leading and socially responsible global company through innovative solutions

Vision

Mission MISSION

Our mission is to be a global organization whose philosophy is characterized by a highly refined sense of ethics which is expressed tangibly through its dealings while upholding highest standards of integrity.

An organization that aspires to be a leader in providing quality healthcare solutions and where patients wellbeing is viewed as the ultimate concern.

Creates differentiation through pioneer ship in Cause Oriented Marketing.Cares for its employees, recognizes merit through rewards on achievements. Bears a progressive approach thereby encouraging initiatives, welcoming new ideas and always ready to move off the beaten track.Respects the hands that help relief pain and suffering.Embraces Information Technology as heart of the business and employs leading technologies to help achieve defined objectives.

Seeks to assure fair returns on investments through sustainability and growth

PharmEvo Private Limited

People More than1,000 people are working at PharmEvo to help save lives and improve quality of life Revenue17 Million USD in just 10 years.ProductsMarketing more than 112 variationsOf Pharmaceutical preparations

PharmEvo Private Limited

SystemPharmEvo is the 1st Pharmaceutical Company in Pakistan to have a complete BMS OTHERS: Integrated Management Systems (ISO 9000, ISO 14000 & ISO 18000)Partnership8 International Partners PharmEvo achieves success through close cooperation with partners who share a commonvision and complementary strengths.

Our Partners

POLAND

Becton Dickinson USA

PRC

Nanjing Aosaikang Medicinal Group, PRC

JAPAN

FRANCE

KOREA

Beijing Kawin Technology Share-Holding Co., Ltd PRC

PharmEvo Private Limited

VietnamMyanmarSri Lanka

Cambodia

Guatemala

Kenya

AfghanistanLocation Currently we operate in 9 Countries, with our headquarter in Karachi, Pakistan

Philippines

27

Markets under DevelopmentInternational OperationsExport Focus: Far East, Middle East & Africa, CIS, South America, EU Countries

PharmEvo Private Limited

MalaysiaTanzaniaYemen

Uzbekistan

Kazakhstan

28

HR Total group employees around 3,513DISTRIBUTION NETWORK 2,000 SKUs, 500 vans,14,00 Sales Personnel's, 8 visits a week to 25,000 30,000 pharmaciesTURNOVER Groups turnover is over Rs.18 Billion (US $210 Million)Our Strengths

PharmEvo Private Limited

29

RESEARCH One of the hallmarks of PharmEvos success is providing local clinical data to the medical community through Clinision Department MARKETING Has Positioned our company as an organization that goes beyond physical healthcare And has Established brands and Corporate imageQUALITY PharmEvos Success Story Starts from Quality Product, Which is maintained through our high professionals in Production Our Strengths

PharmEvo Private Limited

30

BUSINESS DEVELOPMENT &LICENSINGThroughStrategic Alliances, Portfolio Management & Developing New MarketsOur Strengths

PharmEvo Private Limited

(Pakistan Operations)Total PharmEvo Brand Sales from 2000 2011, 2012 Target (Rs.2,000 Million) = USD 24 Million

PharmEvos Ranking BY IMS Health, Pakistan.

1999 400th2012 31st

2006 70th

Total & PHARMEVO Sales trend over last 5 yearsPHARMEVORs. Mn PHARMEVO has an upward Sales in 3Q 2011, CAGR is 27.72% which is higher than Total Market and NationalsMKTCAGR 11 Vs 07TOTAL MKT. 15.89%NATIONAL18.05%PHARMEVO 27.72%

3rd Qtr 2011

% PHARMEVO has shown better growth in 3Q 2011 as compared to same period last year 3rd Qtr 2011Total & PHARMEVO Growth trend over last 4 years

% PHARMEVO has shown better growth in 3Q 2011 as compared to same period last year 3rd Qtr 2011Total & PHARMEVO Unit Growth trend over last 4 years

Earning Award of Excellence

PharmEvos Products in Therapeutic Segments BIO-TECHHYPOLIPIDAEMICANTI-PEPTIC ULCERANTANTI-INFECTIVE / ANTIBIOTICANTI-HISTAMINICANTI-PLATELET AGGREGATORANALGESICSBONE CALCIUM REGULATORANTI-OBESITYANABOLIC / HAEMATOPOETICSANTI-EPILEPTICIRON-PREPARATIONANTI-PSYCHOTICANTI-HYPERTENSIVEANTI-DIABETICNUTRITIONDIAGNOSTICSANTI-NEOPLASTICSANTI-RHEUMATOLOGICALS

At PharmEvo we have infrastructure and expertise to conduct PHASE-II - IV clinical studies At present we are highly engaged / involved in Phase IV clinical trialsOne of the hallmarks of PharmEvos success is providing local clinical data to the medical communityUp till now we have conducted clinical trials on local population in Cardiovascular, Diabetes, Analgesic & Anti-Infective segments

Marketing Strategies Medical Involvement

Aggressive Promotion

Skilled Sales ForceAchieveCustomer Satisfaction

Marketing Philosophy / ActivitiesUnique Books publication and distributionThematic calendars since 2000Sponsoring Digital libraries in large hospitals and medical schoolsRewards and Incentives to Medical StudentsLocal User TrialsVideo ShowsSkill development opportunities for medical professionalsCareer guidance workshops for young students

Statistical and Training Services Provided by ClinisionTotal 245 Statistical services requests completed

Research Data Compiling Training Services Provided to Doctors by Clinision- A PharmEvos DivisionTotal Doctors Trained so Far 1,932

International CSR Activities

Symposium Organized At Cambodia

National Activities

Pakistan Chest Society

Manufacturer

National Distributor/Company's Own distribution

Dispensing DoctorsRetailer

Wholesaler

Govt./Pvt.Hospitals/Clinics

Consumer

Preferred Dealers

Cytotoxic drugsNormal

Distribution Network

Manufacturing Facility Overview10 Acre Facility, Michael Taylor ConsultantModernized Manufacturing Facility As Per GMP & FDA RequirementsIMS accreditation (ISO 9001:2000-QMS), (ISO 14001:2004-EMS) & (ISO 18001:2000_OHSAS).Completely Separate Buildings For Cephalosporin & Non-Cephalosporin Products As Per WHO Guidelines

Manufacturing Facility

Manufacturing Facility Expansion Plan

Main Features Dedicated building for the formulation of Cephalosporin21 Air handling units installed in operational areas

Building Management System (BMS) from Honeywell

SectionsCapsule SectionTablet SectionOral liquid SectionOintment Section WarehousePackaging Quality AssuranceTotal Production area - 16,000 Sq. Ft.

Production Area Main BuildingNon-Sensitive Pharmaceuticals

SectionsCapsule SectionTablet SectionDry Powder SuspensionComponents washing & sterilization Sterile Injection SectionPackaging SectionMaterial Handling SectionTotal Production area 9,000 Sq. Ft.

Production Area Cephalosporin's

Quality Assurance

No Compromise On Quality ZERO TOLERANCE POLICY

Fully Equipped Laboratory

Latest Equipment's For Complete Analysis Of Products

PharmEvo is the first pharmaceutical company in Pakistan to have a complete BMS.

Building Management System -BMS

Online Monitoring & Control Of

Manufacturing room parametersAir Flow & VolumeRelative HumidityAir Handling UnitsAir Filtration SystemHEPA Filter Performance For GMP Compliance

Manufacturing As Per Pharmacopeial Specifications.

Salient features - BMS

BMS-Main Page

BMS-System Architecture

BMS-Power Operation Monitoring

BMS-AHU Status on Main Building

BMS-AHU Monitoring & Control

Thank you !BMS-Water System Monitoring & Control

OrganogramBOARD OF DIRECTORS:Ebrahim QassimGroup ChairmanDerek EvansChairman PharmEvoM. Haroon QassimManaging DirectorZamiruddin AhmedDirector

Ebrahim Qassim (Group Chairman)Chartered Accountant40 years of experience ranging from Pharmaceuticals, Distribution, and Textiles to Consumer GoodsServed on many professional organizations, including KSE, ICAP, MAP, etc.A renowned and respected industrialist

Derek Alan Evans (Chairman PharmEvo)Derek joined Searle in 1963 and served until 1987 when he retired as Vice President for Searle operation in Europe.Appointment in National Health Service (NHS) of the West London Health Authority in 1998.Chairman of Stoke Mandeville Hospital which is the largest paraplegic hospital in Europe from which he retired in 2005

Key Personnel

M. Haroon Qassim (Managing Director)

CPA and MBA (USA)17 years of experience ranging from Distribution & Finance to Pharmaceuticals.Ex-Chairman Pakistan Pharmaceutical Manufacturers Association. ( PPMA )

Dr. Munir Anwar (Director Technical )

MBA, PhD in Pharmacognosy from University of Karachi32 years experience in Pharmaceutical Manufacturing

Key Personnel (Continued..)

S. Jamshed Ahmad (Director Marketing& Sales)

B. Pharm, MBA Pharmaceutical Marketing USA. 17 Years Experience in Pharmaceutical Marketing

M. Nadeem Rehmat (Director Business Development)

B.Pharm, MBAOver 17 years of experience in Pharmaceutical Industry / Business Development

Key Personnel (Continued..)

What Pakistan Offers?A Positive Shift In Perception Of Doctors Towards National CompaniesHigh-Quality Human ResourcesAuxiliary Industries EstablishedEasy Access To CIS (Central independent State)

What PharmEvo Offers?700+Medical RepsIn PakistanMost Credible Corporate ImageExpertise InTop 8 Therapeutic Categories Business Ethics & Knowledge Based PhilosophyAggressive & Responsive CultureEnsured Quality

What Are We Looking For?

THANK U.

Chart10.360.270.290.70000000010.28

100%% Urban Population Out of Total Population

Sheet1PakistanBangladeshIndiaMalaysiaVietnam100%36%27%29%70%0.28

Chart18377

10%Physician Per 10,000 Population6

Sheet1PakistanBangladeshIndiaMalaysia10%800%300%700%700%

Chart112.5455380165250380507670900100014502000

TotalTarget 2,000

Sheet12000200120022003200420052006200720082009201020112012Total12.5455380165250380507670900100014502000

Chart189449256804465102022994985923701000585227165344892173267209584211885521851964697015811884523539135013402269735874023771040661257161357804072901978618481326706368

TotalNATIONALPHARMEVO

Sheet120072008200920102011Total89,449,256,804100,058,522,716118,855,218,519135,013,402,269161,357,804,072NATIONAL46,510,202,29953,448,921,73264,697,015,81173,587,402,37790,197,861,848PHARMEVO498,592,370672,095,842884,523,5391,040,661,2571,326,706,368

Chart111.8614.9234.818.7921.0431.6113.5913.7417.6519.5122.5727.49

TotalNATIONALPHARMEVOYears

Sheet1Years2008200920102011Total11.8618.7913.5919.51NATIONAL14.9221.0413.7422.57PHARMEVO34.8031.6117.6527.49

Chart16.277.7425.7710.9412.8823.855.956.458.0110.7814.3215.28

TotalNATIONALPHARMEVOYears

Sheet1Years2008200920102011Total6.2710.945.9510.78NATIONAL7.7412.886.4514.32PHARMEVO25.7723.858.0115.28